Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03190278
Title Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia
Acronym AMELI-01
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cellectis S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.